Advertisement

Topics

Expanded Technologies Incorporated Company Profile

10:42 EDT 21st March 2019 | BioPortfolio

Expanded Technologies Incorporated is an international consortium of experienced hardware and software designers with over 30 years of experience in data acquisition and analysis technologies. Our engineers have extensive experience in bio-monitoring device design and understand the special regulatory issues faced by the distributors of bio-monitoring systems.

Location

United States of America

Contact

Phone: 1-318-865-5941
Email: sales@vi-lab.com


News Articles [609 Associated News Articles listed on BioPortfolio]

Bioclinica Introduces Expanded ‘SMART’ Technology Suite

Combines clinical trial technologies for all essential activities in a common data set

AstraZeneca gets FDA expanded approval for Farxiga and Xigduo XR

The expanded Farxiga and Xigduo XR labels have been approved to treat patients with T2D and moderate renal impairment, which is a chronic kidney disease with an estimated The post AstraZeneca gets FD...

UK's NICE gives early no to expanded use of AstraZeneca's Lynparza

In a draft decision, a committee for the U.K.'s cost watchdog recommended not providing coverage for expanded use of the PARP inhibitor in ovarian cancer.

PCI invests $20m into biotech & cold chain

Global biopharmaceutical services provider PCI Pharma Services (PCI) has expanded its biotech technologies with an investment drive of over $20 million.

CERESPIR INCORPORATED and the NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE Announce Positive Data Showing Beneficial Effects of CERESPIR’s Clinical Stage Compound Itanapraced in a LRRK2 Model of Parkinson’s Disease 

Itanapraced blocks LRRK2 expression and LRRK2-mediated neurotoxicity Itanapraced ready to advance to Phase 2 in Parkinson’s disease patients with and without genetic mutation NEW YORK and SINGAPO...

Opinion: It’s time to get serious about the economics of expanded access

"Right to try" doesn't mean right to try for free. So who should pay for expanded access to experimental medicines, and how much should they pay?

@Expanded_Access Expanded Access Summit

@SteveUsdin1 to speak at the big Expanded Access 2.0 event this January 22-23, 2019, at the National Press Club. #expandedaccess #clinicaltrials #patients Register Here:

Millar gets expanded CE mark for Mikro-Cath pressure catheter

The CE mark for Mikro-Cath has been expanded to include airway and intra-compartmental pressure measurements, which will allow European physicians and clinical researchers to access high-fidelity pres...

PubMed Articles [549 Associated PubMed Articles listed on BioPortfolio]

Musculoskeletal Imaging: Current Practice and Future Directions.

Musculoskeletal (MSK) radiology plays a crucial role in the diagnosis and management of MSK disorders and has rapidly expanded in tandem with advances in technology and improved access to imaging. Alt...

Advances in Health Technology Use and Implementation in the Era of Healthy Living: Implications for Precision Medicine.

Much of the focus of precision medicine has been directed toward genomics, despite the fact that "lifestyle and behavioral factors" are included in the description of precision medicine. Numerous stru...

Thallium pollution in China and removal technologies for waters: A review.

Thallium (Tl) is a typical toxic metal, which poses a great threat to human health through drinking water and the food chain (biomagnification). China has rich Tl-bearing mineral resources, which have...

The delivery of ambulatory diabetes care to children and adolescents with diabetes.

In this update, we have expanded general guidelines on current diabetes technologies, transition from pediatric to adult care, anticipatory guidance, and barriers to care. This article is protected by...

Is Expanded Hemodialysis an Option to Online Hemodiafiltration for Small- and Middle-Sized Molecules Clearance?

Recent evidence suggests a better reduction rate of some uremic toxins with expanded hemodialysis (HDx).

Clinical Trials [1073 Associated Clinical Trials listed on BioPortfolio]

Expanded Access of Vigil in Solid Tumors

This is a multicenter, expanded access protocol of intradermal autologous Vigil immunotherapy. Subjects meeting expanded access eligibility criteria will receive a minimum of 1 immunothera...

Individual Patient Expanded Access for AB-SA01, an Investigational Anti-Staphylococcus Aureus Bacteriophage Therapeutic

The purpose of the expanded access program is to allow physicians to provide treatment with investigational drug, AB-SA01, for patients with serious or immediately life-threatening Staphyl...

Individual Patient Expanded Access for AB-PA01, an Investigational Anti-Pseudomonas Aeruginosa Bacteriophage Therapeutic

The purpose of the expanded access program is to allow physicians to provide treatment with investigational drug, AB-PA01, for patients with serious or immediately life-threatening Pseudom...

Nivolumab in the Real World: Analysis of the Expanded Use in Spanish Patient

We will retrospectively review the case note of patients registered in the EAP of Nivolumab. A standard anonymous data collection form will be used to collect data and to analyze it. Pat...

Expanded Access to Omaveloxolone for Melanoma for Patients Previously Enrolled in 408-C-1401

This is an expanded access program for eligible participants and is designed to provide access to omaveloxolone for the treatment of unresectable or metastatic melanoma to patients who pre...

Companies [1692 Associated Companies listed on BioPortfolio]

Expanded Technologies Incorporated

Expanded Technologies Incorporated is an international consortium of experienced hardware and software designers with over 30 years of experience in data acquisition and analysis technologies. Our eng...

Pharmapraxis

Founded in 2008 by the Axis Biotec Brasil™ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

DGN Technologies, Inc.

DGN Technologies, Inc. is a leading provider of solutions in support of SAP applications, providing both expert services and cutting-edge tools. Launched in 2000 to provide consulting services in the...

Champion Technologies

Champion Technologies (a Permian Mud Service, Inc. company) is the largest privately owned oilfield chemical company. Champion is a global supplier of a complete line of proprietary specialty chemical...

More Information about "Expanded Technologies Incorporated" on BioPortfolio

We have published hundreds of Expanded Technologies Incorporated news stories on BioPortfolio along with dozens of Expanded Technologies Incorporated Clinical Trials and PubMed Articles about Expanded Technologies Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Expanded Technologies Incorporated Companies in our database. You can also find out about relevant Expanded Technologies Incorporated Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record